STRATA Skin Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2002
Net Income	-10.83	-5.55	-2.71	-4.39	-3.6	-2.91	-8.85	-3.34	-27.91	-16.03	Upgrade
Depreciation & Amortization	5.9	5.69	4.09	3.91	4.82	5.4	6.34	6.37	4.05	1.79	Upgrade
Share-Based Compensation	1.3	1.47	1.64	1.63	1.2	0.9	0.19	0.11	1.75	0.41	Upgrade
Other Operating Activities	3.11	-2.53	-1.52	0.95	-0.19	-0.5	6.47	-2.82	12.57	-5.77	Upgrade
Operating Cash Flow	-0.52	-0.92	1.51	2.1	2.23	2.9	4.14	0.32	-6.57	-17.71	Upgrade
Operating Cash Flow Growth	-	-	-28.05%	-5.97%	-23.03%	-30.05%	1185.71%	-	-	-	Upgrade
Capital Expenditures	-5.02	-3.74	-3.65	-2.16	-2.79	-1.76	-2.06	-1.01	-1.72	0.02	Upgrade
Acquisitions	0	-0.63	-3.47	0	0	0	0	0.13	-42.5	0	Upgrade
Other Investing Activities	-	-	-	-	-	-0.02	-0.14	0.02	-0.02	-	Upgrade
Investing Cash Flow	-5.02	-4.37	-7.13	-2.16	-2.79	-1.79	-2.19	-0.87	-44.24	0.02	Upgrade
Share Issuance / Repurchase	0	0	0	0.02	0	17	0	0	0	11.46	Upgrade
Debt Issued / Paid	6.9	0	0.09	2.53	-0.3	-3.36	-1.8	1.17	42.8	15	Upgrade
Other Financing Activities	-0.04	-0.5	-	-	-	-2.34	-	-	-0.13	-1.12	Upgrade
Financing Cash Flow	6.86	-0.5	0.09	2.55	-0.3	11.31	-1.8	1.17	42.67	25.34	Upgrade
Exchange Rate Effect	0	0	0	0	0	0	-0	0	0.01	0	Upgrade
Net Cash Flow	1.32	-5.79	-5.53	2.48	-0.86	12.42	0.14	0.63	-8.13	7.65	Upgrade
Free Cash Flow	-5.54	-4.66	-2.15	-0.06	-0.56	1.13	2.08	-0.69	-8.29	-17.69	Upgrade
Free Cash Flow Growth	-	-	-	-	-	-45.51%	-	-	-	-	Upgrade
Free Cash Flow Margin	-16.60%	-12.89%	-7.16%	-0.27%	-1.78%	3.80%	6.55%	-2.23%	-44.84%	-1933.55%	Upgrade
Free Cash Flow Per Share	-0.16	-0.13	-0.06	-0.00	-0.02	0.06	0.77	-0.32	-4.86	-16.70	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).